Provided by Tiger Trade Technology Pte. Ltd.

AEON Biopharma

1.07
-0.0600-5.31%
Post-market: 1.110.0400+3.74%17:51 EDT
Volume:64.65K
Turnover:70.73K
Market Cap:12.95M
PE:0.22
High:1.17
Open:1.12
Low:1.07
Close:1.13
52wk High:1.45
52wk Low:0.3750
Shares:12.11M
Float Shares:8.66M
Volume Ratio:1.83
T/O Rate:0.75%
Dividend:- -
Dividend Rate:- -
EPS(TTM):4.87
EPS(LYR):72.93
ROE:--
ROA:-165.52%
PB:-0.65
PE(LYR):0.01

Loading ...

BRIEF-Aeon Biopharma Announces Execution Of Exchange Agreement With Daewoong

Reuters
·
Dec 16, 2025

AEON Biopharma Strikes Debt-for-Equity Deal With Daewoong

Reuters
·
Dec 16, 2025

AEON Biopharma Announces Execution of Exchange Agreement With Daewoong

THOMSON REUTERS
·
Dec 16, 2025

AEON Biopharma Inc - Exchange to Eliminate Over 90% of AEON's Outstanding Debt

THOMSON REUTERS
·
Dec 16, 2025

AEON Biopharma Inc - Co and Daewoong Execute $15 Mln Notes Exchange Agreement Plus Accrued Interest Into New Equity

THOMSON REUTERS
·
Dec 16, 2025

AEON Biopharma Unveils Strategy for Full-Label Botox Biosimilar Approval

Reuters
·
Dec 04, 2025

AEON Launches Tender Offer for TSURUHA HOLDINGS Shares

MT Newswires Live
·
Dec 02, 2025

AEON Credit Announces Director Resignation

TIPRANKS
·
Nov 28, 2025

AEON CREDIT (00900): Ms. Jin Huashu Resigns as Non-Executive Director

Stock News
·
Nov 28, 2025

AEON Financial Service to Absorb Subsidiary’s Data Analysis Business

TIPRANKS
·
Nov 28, 2025

AEON Biopharma Inc - First Closing of Pipe Results in $1.79 Mln Proceeds

THOMSON REUTERS
·
Nov 20, 2025

AEON Biopharma Inc: FDA Bpd Type 2a Meeting NOW Scheduled for January 21, 2026

THOMSON REUTERS
·
Nov 20, 2025

AEON Biopharma Announces First Closing of PIPE Investment and Provides Update on FDA Type 2a Meeting Scheduling

GlobeNewswire
·
Nov 20, 2025

AEON Stores Renews Key Agreements and Revises Purchase Caps

TIPRANKS
·
Nov 18, 2025

AEON Fantasy Reports Strong October Sales Growth

TIPRANKS
·
Nov 17, 2025

Aeon Biopharma Reports Positive Data and Strategic Moves

TIPRANKS
·
Nov 15, 2025

AEON Biopharma Q3 EPS $(0.39) Beats $(0.43) Estimate

Benzinga
·
Nov 14, 2025

AEON Biopharma Slashes Debt by Over 90% with Strategic Transactions

Reuters
·
Nov 14, 2025

AEON Biopharma Inc: Qtrly EPS $-0.39

THOMSON REUTERS
·
Nov 14, 2025

Press Release: AEON Biopharma Reports Third Quarter 2025 Results, Including Positive ABP-450 Biosimilarity Data and Strategic Positioning for Continued Growth

Dow Jones
·
Nov 14, 2025